Squarepoint’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.9M Sell
177,800
-9,600
-5% -$2.55M 0.09% 201
2026
Q1
$20.5M Sell
187,400
-148,800
-44% -$21.2M 0.02% 695
2025
Q4
$55.9M Buy
336,200
+137,100
+69% +$22.9M 0.06% 369
2025
Q3
$39M Sell
199,100
-48,500
-20% -$7.98M 0.04% 488
2025
Q2
$22.4M Buy
247,600
+114,000
+85% +$9.01M 0.02% 714
2025
Q1
$7.97M Buy
133,600
+100,200
+300% +$9.27M 0.01% 1134
2024
Q4
$4.42M Buy
33,400
+13,300
+66% +$1.25M ﹤0.01% 1742
2024
Q3
$1.05M Hold
20,100
﹤0.01% 2569
2024
Q2
$1.22M Buy
+20,100
New +$1.39M ﹤0.01% 2414

Other funds holding ALAB

Squarepoint's ALAB Position: Q2 2026 in Review

Squarepoint increased its Astera Labs (ALAB) stake by 124% in Q2 2026, buying an estimated $46.6M and bringing the position to 317,208 shares worth $153M. The position accounts for 0.17% of the portfolio, ranked #102.

Squarepoint first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Squarepoint held 317,208 shares of Astera Labs worth $153M as of Q2 2026.
  • Squarepoint bought 175,651 Astera Labs shares in Q2 2026, an estimated $46.6M.
  • Astera Labs made up 0.17% of Squarepoint's portfolio in Q2 2026, its #102 holding.
  • Squarepoint first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.